Ubrogepant for the Treatment of Migraine.

Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, Szegedi A. Ubrogepant for the Treatment of Migraine. N Engl J Med. 2019 12 05; 381(23):2230-2241.

View in: PubMed

subject areas

Adult
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Hyperacusis
Kaplan-Meier Estimate
Male
Migraine Disorders
Nausea
Pain Management
Photophobia
Pyridines
Pyrroles

authors with profiles

David Dodick

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement